𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis

✍ Scribed by Johann Christian Bode; Peter Hanisch; Harald Henning; Wolfgang Koenig; Friedrich-Wilhelm Richter; Christiane Bode


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
646 KB
Volume
8
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


The hepatic zinc content was determined in liver biopsies of patients with alcoholic and nonalcoholic liver disease using proton-induced X-ray emission. The values obtained in postmortem specimens of the liver from 27 patients with no evidence of acute or chronic liver disease served as controls. The mean value and the range of the zinc content in the controls (75 f 24 ppm wet weight) are in good agreement with those reported in the literature. The hepatic zinc content in the control group showed no significant age or sex dependence. The mean zinc content was significantly decreased in all groups of patients with alcoholic liver disease. The decrease was comparable in biopsies from patients with alcoholic fatty liver (-56.7%, n = 12), mild alcoholic hepatitis (-50.5%, n = 6) and alcoholic cirrhosis (-45.6%, n = 10). The hepatic zinc content was also distinctly reduced in patients with chronic active hepatitis (-60.3%, n = 15) and in those with chronic persistent hepatitis (-44.9%, n = 8). The estimation of the zinc content in subcellular fractions of the liver performed in postmortem specimens from seven patients with alcoholic liver cirrhosis and in six controls revealed a significant reduction in the zinc content in the fraction containing cell nuclei and membranes and in the mitochondrial fraction. A similar decrease was seen in the 100,000 g supernatant; however, the difference did not attain statistical difference. The zinc content of the microsomal fraction in the controls was lower than in the other three cell fractions. There was no significant difference in microsomal zinc content between the samples of the two groups studied. The results of this study underline the fact that zinc deficiency in the liver occurs not only in cirrhotics but also in less advanced alcoholic and nonalcoholic liver disease.

The existence of zinc deficiency in patients with alcoholic cirrhosis was first shown by Vallee et al. (1). They


πŸ“œ SIMILAR VOLUMES


Hepatic stellate cell activation in live
✍ Laura Cisneros; Maria-Carlota LondoΓ±o; Carmen Blasco; RamΓ³n Bataller; Rosa Mique πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

The pathogenic mechanisms of accelerated graft fibrosis in hepatitis C recurrence after liver transplantation (LT) are not well established. The aim of the study was to assess whether a greater activation of hepatic stellate cells (HSC), the major collagen-producing cells in the liver, can occur in

Safety and immunogenicity of hepatitis A
✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Hepatitis B virus subtypes and hepatitis
✍ Santosh Man Shrestha; Fumio Tsuda; Hiroaki Okamoto; Hajime Tokita; Minoru Horiki πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 595 KB

A total of 146 patients with chronic liver disease, including 20 with chronic hepatitis, 63 with cirrhosis and 62 with primary hepatocellular carcinoma from Nepal were tested for markers of hepatitis B virus or hepatitis C virus infection. HBsAg was detected in 57 (39%) and hepatitis C virus RNA in

Safety and immunogenicity of inactivated
✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 298 KB πŸ‘ 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec